Cleveland Clinic's Top 10 Medical Innovations For 2009
This article was originally published in The Gray Sheet
1. Use of circulating tumor cell technology: A blood test assessing chemotherapy progress by measuring for cancer cells that have broken away from an existing tumor and entered the bloodstream.
You may also be interested in...
Synapse Biomedical will pursue expanded approval of its diaphragm pacing system to facilitate breathing in patients with Lou Gehrig's disease after gaining a humanitarian device exemption June 17 for use by ventilator-dependent spinal cord injury patients, according to the company
Perelel doubles its support and makes $10m pledge to women’s health research groups; Odyssey Wellness starts boosting brand visibility for energy drinks with lion’s mane and cordyceps mushrooms.
Following request by Universities Allied for Essential Medicines, FDA creates a public dashboard of pre-notices of noncompliance on registering trials and submitting results to ClinicalTrials.gov. The agency denies request to impose civil penalties on those who fail to comply, citing its discretion.